| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Farhana Akter | |
| Gerry Coghlan | |||
| Achala de Mel | |||
| P2860 | cites work | Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome | Q24202890 |
| High flow nasal cannula for respiratory support in preterm infants | Q24234509 | ||
| Nitric oxide and peroxynitrite in health and disease | Q24645400 | ||
| Tracheal replacement | Q26765091 | ||
| An update on pharmacologic approaches to bronchopulmonary dysplasia | Q26825139 | ||
| Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia | Q30475217 | ||
| Nitrogen dioxide formation during inhaled nitric oxide therapy | Q30650897 | ||
| NO-independent regulatory site on soluble guanylate cyclase | Q32165040 | ||
| Riociguat for the treatment of pulmonary arterial hypertension | Q33163083 | ||
| Two-year neurodevelopmental outcomes of ventilated preterm infants treated with inhaled nitric oxide | Q33746358 | ||
| Prolonged mechanical ventilation alters diaphragmatic structure and function | Q34018761 | ||
| Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. | Q34378124 | ||
| Inhaled nitric oxide in preterm infants undergoing mechanical ventilation | Q34551446 | ||
| Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies | Q35044042 | ||
| Intensive care unit readmission during childhood after preterm birth with respiratory failure | Q35081713 | ||
| Indications and interventional options for non-resectable tracheal stenosis | Q35119409 | ||
| Combined-modality therapy with inhaled nitric oxide and exogenous surfactant in term infants with acute respiratory failure | Q35157087 | ||
| Nanocarriers for nitric oxide delivery | Q35176430 | ||
| Structurally Diverse Nitric Oxide-Releasing Poly(propylene Imine) Dendrimers | Q35485272 | ||
| Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension | Q35543584 | ||
| Encapsulation of PROLI/NO in biodegradable microparticles | Q44724988 | ||
| Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial | Q45025783 | ||
| Variation in the management of persistent pulmonary hypertension of the newborn: a survey of physicians in Canada, Australia, and New Zealand | Q45026666 | ||
| Nitric oxide augments fetal pulmonary artery endothelial cell angiogenesis in vitro | Q46884622 | ||
| Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin | Q47205871 | ||
| Delivery of inhaled nitric oxide using the Ohmeda INOvent Delivery System. | Q51515533 | ||
| Inhaled nitric oxide in premature infants with the respiratory distress syndrome. | Q51641105 | ||
| Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. | Q51711116 | ||
| Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. | Q52510019 | ||
| Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis. | Q53112801 | ||
| Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn | Q60146859 | ||
| Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn | Q67521838 | ||
| Variation of nitric oxide concentration during inspiration | Q73075667 | ||
| Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure | Q73080410 | ||
| Inaccuracies of nitric oxide delivery systems during adult mechanical ventilation | Q73146646 | ||
| Inhaled nitric oxide in neonates with persistent pulmonary hypertension | Q73485883 | ||
| Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children | Q80134666 | ||
| Interventional pulmonology | Q82232058 | ||
| Inhaled nitric oxide to prevent bronchopulmonary dysplasia in preterm infants--less than a silver bullet | Q85650234 | ||
| Early inhaled nitric oxide at high dose enhances rat lung development after birth | Q87352059 | ||
| Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia | Q87520772 | ||
| Clinical review: the ABC of weaning failure--a structured approach | Q35561430 | ||
| Pulmonary hypertension in bronchopulmonary dysplasia | Q35731631 | ||
| Inhaled NO as a therapeutic agent | Q36003322 | ||
| Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors | Q36138113 | ||
| Can nitric oxide-based therapy prevent bronchopulmonary dysplasia? | Q36220974 | ||
| Nitric oxide-releasing dendrimers as antibacterial agents | Q36352418 | ||
| Critical illness and mechanical ventilation: effects on the diaphragm. | Q36577994 | ||
| The pulmonary circulation in neonatal respiratory failure | Q36687766 | ||
| Successful Treatment of a Neonate with Idiopathic Persistent Pulmonary Hypertension with Inhaled Nitric Oxide via Nasal Cannula without Mechanical Ventilation | Q36842666 | ||
| Guidelines for Rational and Cost-Effective Use of iNO Therapy in Term and Preterm Infants | Q37094554 | ||
| Circulating endothelial progenitor cells decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide | Q37297614 | ||
| One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial | Q37350512 | ||
| Inhaled nitric oxide in the neonate | Q37462138 | ||
| Bench-to-bedside review: Inhaled nitric oxide therapy in adults | Q37516577 | ||
| What is the real physiological NO concentration in vivo? | Q37551307 | ||
| Neonatal pulmonary hypertension | Q37705885 | ||
| Inhaled nitric oxide in preterm infants: a systematic review | Q37827270 | ||
| NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. | Q37827272 | ||
| Patient-ventilator interaction during acute lung injury, and the role of spontaneous breathing: part 1: respiratory muscle function during critical illness | Q37844711 | ||
| Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis | Q37849472 | ||
| Nitric oxide: a guardian for vascular grafts? | Q37887771 | ||
| Liposomes as drug delivery systems for the treatment of TB. | Q37949386 | ||
| Efficacy of inhaled nitric oxide in preterm neonates | Q37981015 | ||
| Inhaled nitric oxide applications in paediatric practice. | Q37988497 | ||
| Nitric oxide donors for cardiovascular implant applications | Q38058487 | ||
| Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review | Q38176627 | ||
| Advances in bronchopulmonary dysplasia | Q38199172 | ||
| A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome. | Q38204749 | ||
| Photoinduced nitric oxide release from a nitrobenzene derivative in mitochondria | Q39576045 | ||
| Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids | Q39615775 | ||
| Characterization of nitric oxide-releasing microparticles for the mucosal delivery | Q39868031 | ||
| Ventilator-induced diaphragmatic dysfunction | Q39926522 | ||
| Dendrimers as a scaffold for nitric oxide release | Q40314306 | ||
| Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension | Q41890311 | ||
| Inhaled nitric oxide use in newborns | Q42054728 | ||
| YC-1, a novel activator of platelet guanylate cyclase | Q42275468 | ||
| Effect of nitric oxide on lung surfactant secretion | Q42441147 | ||
| Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure | Q42929570 | ||
| Micelles for delivery of nitric oxide | Q43274626 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 256-270 | |
| P577 | publication date | 2016-05-23 | |
| P1433 | published in | Therapeutic advances in cardiovascular disease | Q26842002 |
| P1476 | title | Nitric oxide in paediatric respiratory disorders: novel interventions to address associated vascular phenomena? | |
| P478 | volume | 10 |
| Q50258998 | Dual-acting biofunctionalised scaffolds for applications in regenerative medicine. | cites work | P2860 |
Search more.